about
Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variantsUpdated overview of current biomarkers in head and neck carcinomaPolymorphisms in the human cytochrome P450 and arylamine N-acetyltransferase: susceptibility to head and neck cancersPolymorphisms in human DNA repair genes and head and neck squamous cell carcinomaMetabolomics of Head and Neck Cancer: A Mini-ReviewToward the use of precision medicine for the treatment of head and neck squamous cell carcinomaPreclinical evaluation of dual PI3K-mTOR inhibitors and histone deacetylase inhibitors in head and neck squamous cell carcinomaRUNX3 has an oncogenic role in head and neck cancerSusceptibility of human head and neck cancer cells to combined inhibition of glutathione and thioredoxin metabolismMMP-10/stromelysin-2 promotes invasion of head and neck cancer.Selaginellatamariscina attenuates metastasis via Akt pathways in oral cancer cells.Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profilesUrokinase plasminogen activator receptor (uPAR) and plasminogen activator inhibitor-1 (PAI-1) are potential predictive biomarkers in early stage oral squamous cell carcinomas (OSCC)Efficient targeting of head and neck squamous cell carcinoma by systemic administration of a dual uPA and MMP-activated engineered anthrax toxin.[Translational research in head and neck cancer. Biological characteristics and general aspects].Molecular signatures of metastasis in head and neck cancer.New vessel formation in peritumoral area of squamous cell carcinoma of the head and neck.Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data.Integrative molecular characterization of head and neck cancer cell model genomesInduction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia.Periostin directly and indirectly promotes tumor lymphangiogenesis of head and neck cancer.Activation of Akt at T308 and S473 in alcohol, tobacco and HPV-induced HNSCC: is there evidence to support a prognostic or diagnostic role?Deciphering squamous cell carcinoma using multidimensional genomic approaches.Longitudinal imaging studies of tumor microenvironment in mice treated with the mTOR inhibitor rapamycin.Loss of transforming growth factor-beta type II receptor promotes metastatic head-and-neck squamous cell carcinoma.Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis.Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway.Whole transcriptome sequencing identifies tumor-specific mutations in human oral squamous cell carcinoma.MicroRNA expression profile in head and neck cancer: HOX-cluster embedded microRNA-196a and microRNA-10b dysregulation implicated in cell proliferation.Emerging strategies for the early detection and prevention of head and neck squamous cell cancerFunctional characterization of OPN in human laryngeal squamous cell carcinoma and its xenograft model in nude miceProteomic analysis of oral cavity squamous cell carcinoma specimens identifies patient outcome-associated proteinsEffects of the administration of epidermal growth factor receptor specific inhibitor cetuximab, alone and in combination with cisplatin, on proliferation and apoptosis of Hep-2 laryngeal cancer cells.Elevated ZNF703 Protein Expression Is an Independent Unfavorable Prognostic Factor for Survival of the Patients with Head and Neck Squamous Cell CarcinomaLoss of TGF-β signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation.Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkers.A novel approach for determining cancer genomic breakpoints in the presence of normal DNAPlectin as a prognostic marker in non-metastatic oral squamous cell carcinomaPTX3 gene activation in EGF-induced head and neck cancer cell metastasis.Methylation of microRNA-9 is a specific and sensitive biomarker for oral and oropharyngeal squamous cell carcinomas.
P2860
Q24624194-6DB5CB80-E8C6-4D9F-8CB5-D13737934018Q26750659-7B5C25EB-7B24-4B3E-BF7D-8EB35BFC262BQ27010137-AF90B440-15B7-4694-8C48-01D2D01FBF1FQ27015116-80ADC63C-EEF0-476C-80F5-D8668008BCA9Q28069660-ED15C7FE-B096-469E-8532-E27F3CDBEAF8Q28074691-C49522E2-4844-4685-8C68-7ABBE9218791Q28395338-6CEF1C01-22B2-4486-B3F3-04FCF3B4F22FQ28475605-E3F0C853-E43E-440A-B077-0E2CAADE9041Q28484655-7C54E6E1-5EBA-4C35-8F6B-214BB81C98C0Q31036986-6B0897CA-CCFA-4275-959E-5DFBF6894018Q31121466-11E4D8EF-4FF6-45B6-8149-1C4240A1C4ABQ33639706-4BB4B940-03DE-41F7-9CB3-F05EC6155971Q33856467-7EA7AA59-6E3D-4605-948F-59E30B552248Q33927058-7F3293FA-6A5C-4973-96CB-8019711C5CE5Q34000961-4ED9FFDE-8253-482E-BACF-C7CE95EDD75AQ34060131-CD9113B2-8ECF-4168-A7EC-F7556CB90BB4Q34086332-68F1ECCD-DD4F-45FC-8C36-EB2F26873366Q34086381-58305D7E-57E2-434E-A7B9-556A477AC564Q34091528-3D1E52EA-24A2-40A5-8D97-A6BDB4AE3F72Q34338550-9E233175-14C4-462A-AA50-1090E6FFE4C6Q34406774-24CDC1CB-DC32-4AF1-BFB6-AA8267DEED05Q34410251-BA882E9B-A5DF-4265-B2CE-D470D188310DQ34475613-521803B8-3A09-4EB8-9E3F-7B606D0B5963Q34490050-F3F95D4B-5A2D-4955-8C07-AB528E2549D8Q34653637-B1733CCB-8D99-485C-9EFE-9F3104817E42Q34694762-279EFAC5-794C-4C55-BFEC-E9C5E50A2C36Q34955965-16C172D6-0D7F-44A8-BEBD-FA3999F5EA4AQ34978926-2B609031-BD99-497F-951B-77E2FD956721Q35037596-37BC4948-20B0-4BE6-B059-A311C65D35F4Q35172778-403CEB82-3483-4157-AEF5-0DCADF920066Q35173409-0324991B-9431-4484-80A7-9EFEE5E0594FQ35236494-66111988-EF26-45F7-8DC5-D1F2EE205DF9Q35263472-85C7E755-4023-46A4-8DE8-F6716A8A1DA1Q35598855-FC4BB2CE-FC6B-4D06-AC5E-C813A1E7DC1FQ35722714-96B0EFD8-AF62-47E3-AC93-883505480482Q35741628-C2DE018B-45AA-4449-B384-9BBB370918A5Q35741860-E6711D9C-D847-48FE-B27B-3BBC2D58A661Q35755113-979FB13A-6100-4AB1-8BC7-98BEF61F6A8CQ35781404-80A6D1EB-05AA-472F-BB86-EDBDD8AD9695Q35792884-FD7DD5E2-9C72-4DC8-946C-9C8EE42D9229
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Focus on head and neck cancer.
@ast
Focus on head and neck cancer.
@en
type
label
Focus on head and neck cancer.
@ast
Focus on head and neck cancer.
@en
prefLabel
Focus on head and neck cancer.
@ast
Focus on head and neck cancer.
@en
P1433
P1476
Focus on head and neck cancer.
@en
P2093
P304
P356
10.1016/S1535-6108(04)00090-X
P577
2004-04-01T00:00:00Z